Skip to main content
main-content
Erschienen in: Der Kardiologe 2/2016

01.04.2016 | Herztransplantation | CME

Therapieformen bei fortgeschrittener Herzinsuffizienz

„Ventricular assist device“

verfasst von: M.D. P. Pergantis, T. Krabatsch, E. Potapov, F. Schönrath

Erschienen in: Die Kardiologie | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die steigende Zahl der Patienten mit fortgeschrittener Herzinsuffizienz in Zusammenhang mit der Knappheit an Spenderherzen führt zu einem Anstieg der Zahl der Ventricular-assist-device (VAD)-Implantationen. Ziel der VAD-Therapie ist die Verbesserung der Lebenserwartung und der Lebensqualität. Mit dem VAD kann die links- und/oder rechtsventrikuläre Funktion entweder vorübergehend bis zur Herztransplantation, Eignung für die Listung für die Transplantation oder Erholung unterstützt werden. Zunehmende Bedeutung gewinnt auch die permanente Unterstützung. Die Auswahl der VAD-Kandidaten und die rechtzeitige Evaluation und Implantation des geeigneten Systems können den Erfolg der Therapie weiter verbessern. Die frühe Implantation kann mit besseren Ergebnissen verbunden sein.
Literatur
1.
Zurück zum Zitat Kirklin JK, Naftel DC, Pagani FD et al (2015) Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015 Dec;34(12):1495–504. doi:10.1016/j.healun.2015.10.003. Epub 2015 Oct 8 CrossRef Kirklin JK, Naftel DC, Pagani FD et al (2015) Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015 Dec;34(12):1495–504. doi:10.1016/j.healun.2015.10.003. Epub 2015 Oct 8 CrossRef
2.
Zurück zum Zitat Beckmann A, Funkat A‑K, Lewandowski J et al (2015) Cardiac surgery in germany during 2014: a report on behalf of the german society for thoracic and cardiovascular surgery. Thorac Cardiovasc Surg 63:258–269. doi:10.1055/s-0035-1551676 CrossRefPubMed Beckmann A, Funkat A‑K, Lewandowski J et al (2015) Cardiac surgery in germany during 2014: a report on behalf of the german society for thoracic and cardiovascular surgery. Thorac Cardiovasc Surg 63:258–269. doi:10.1055/s-0035-1551676 CrossRefPubMed
3.
Zurück zum Zitat McMurray JJV, Adamopoulos S, Anker SD et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869. doi:10.1093/eurjhf/hfs105 CrossRefPubMed McMurray JJV, Adamopoulos S, Anker SD et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869. doi:10.1093/eurjhf/hfs105 CrossRefPubMed
6.
Zurück zum Zitat Potapov EV, Krabatsch T (2014) Minimally invasive continuous-flow left ventricular assist device implantation: Avoiding a median sternotomy. J Heart Lung Transplant 33:1199–1200. doi:10.1016/j.healun.2014.09.002 CrossRefPubMed Potapov EV, Krabatsch T (2014) Minimally invasive continuous-flow left ventricular assist device implantation: Avoiding a median sternotomy. J Heart Lung Transplant 33:1199–1200. doi:10.1016/j.healun.2014.09.002 CrossRefPubMed
7.
Zurück zum Zitat Park SJ, Milano CA, Tatooles AJ et al (2012) Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 5:241–248. doi:10.1161/CIRCHEARTFAILURE.111.963991 CrossRefPubMed Park SJ, Milano CA, Tatooles AJ et al (2012) Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 5:241–248. doi:10.1161/CIRCHEARTFAILURE.111.963991 CrossRefPubMed
8.
Zurück zum Zitat Krabatsch T, Schweiger M, Dandel M et al (2011) Is bridge to recovery more likely with pulsatile left ventricular assist devices than with nonpulsatile-flow systems? Ann Thorac Surg 91:1335–1340. doi:10.1016/j.athoracsur.2011.01.027 CrossRefPubMed Krabatsch T, Schweiger M, Dandel M et al (2011) Is bridge to recovery more likely with pulsatile left ventricular assist devices than with nonpulsatile-flow systems? Ann Thorac Surg 91:1335–1340. doi:10.1016/j.athoracsur.2011.01.027 CrossRefPubMed
9.
Zurück zum Zitat Stevenson LW, Pagani FD, Young JB et al (2009) INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 28:535–541. doi:10.1016/j.healun.2009.02.015 CrossRefPubMed Stevenson LW, Pagani FD, Young JB et al (2009) INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 28:535–541. doi:10.1016/j.healun.2009.02.015 CrossRefPubMed
10.
Zurück zum Zitat de By TMMH, Mohacsi P, Gummert J et al (2015) The european registry for patients with mechanical circulatory support (EUROMACS): first annual report. Eur J Cardiothorac Surg 47:096–777. doi:10.1093/ejcts/ezv096 de By TMMH, Mohacsi P, Gummert J et al (2015) The european registry for patients with mechanical circulatory support (EUROMACS): first annual report. Eur J Cardiothorac Surg 47:096–777. doi:10.1093/ejcts/ezv096
11.
Zurück zum Zitat Estep JD, Starling RC, Horstmanshof DA et al (2015) Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROaDMaP study. J Am Coll Cardiol 66:1747–1761. doi:10.1016/j.jacc.2015.07.075 CrossRefPubMed Estep JD, Starling RC, Horstmanshof DA et al (2015) Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROaDMaP study. J Am Coll Cardiol 66:1747–1761. doi:10.1016/j.jacc.2015.07.075 CrossRefPubMed
12.
Zurück zum Zitat Riebandt J, Haberl T, Mahr S et al (2014) Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS Level I patients receiving a permanent ventricular assist device. Eur J Cardiothorac Surg 46:486–492 (discussion 492) doi:10.1093/ejcts/ezu093 CrossRefPubMed Riebandt J, Haberl T, Mahr S et al (2014) Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS Level I patients receiving a permanent ventricular assist device. Eur J Cardiothorac Surg 46:486–492 (discussion 492) doi:10.1093/ejcts/ezu093 CrossRefPubMed
13.
Zurück zum Zitat Netuka I, Sood P, Pya Y et al (2015) Fully magnetically levitated left ventricular assist system for treating advanced HF: a Multicenter study. J Am Coll Cardiol 66:2579–2589. doi:10.1016/j.jacc.2015.09.083 CrossRefPubMed Netuka I, Sood P, Pya Y et al (2015) Fully magnetically levitated left ventricular assist system for treating advanced HF: a Multicenter study. J Am Coll Cardiol 66:2579–2589. doi:10.1016/j.jacc.2015.09.083 CrossRefPubMed
14.
Zurück zum Zitat Potapov EV, Stepanenko A, Kaufmann F et al (2013) Thrombosis and cable damage in the HeartWare pump: clinical decisions and surgical technique. ASAIO J 59:37–40. doi:10.1097/MAT.0b013e31827c0d79 CrossRefPubMed Potapov EV, Stepanenko A, Kaufmann F et al (2013) Thrombosis and cable damage in the HeartWare pump: clinical decisions and surgical technique. ASAIO J 59:37–40. doi:10.1097/MAT.0b013e31827c0d79 CrossRefPubMed
15.
Zurück zum Zitat Enriquez AD, Calenda B, Gandhi PU et al (2014) Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device. J Am Coll Cardiol 64:1883–1890. doi:10.1016/j.jacc.2014.07.989 CrossRefPubMed Enriquez AD, Calenda B, Gandhi PU et al (2014) Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device. J Am Coll Cardiol 64:1883–1890. doi:10.1016/j.jacc.2014.07.989 CrossRefPubMed
16.
Zurück zum Zitat Makki N, Mesubi O, Steyers C et al (2015) Meta-analysis of the relation of ventricular arrhythmias to all-cause mortality after implantation of a left ventricular assist device. Am J Cardiol 116:1385–1390. doi:10.1016/j.amjcard.2015.07.065 CrossRefPubMed Makki N, Mesubi O, Steyers C et al (2015) Meta-analysis of the relation of ventricular arrhythmias to all-cause mortality after implantation of a left ventricular assist device. Am J Cardiol 116:1385–1390. doi:10.1016/j.amjcard.2015.07.065 CrossRefPubMed
17.
Zurück zum Zitat Gopinathannair R, Birks EJ, Trivedi JR et al (2015) Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices. J Card Fail 21:226–232. doi:10.1016/j.cardfail.2014.12.006 CrossRefPubMed Gopinathannair R, Birks EJ, Trivedi JR et al (2015) Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices. J Card Fail 21:226–232. doi:10.1016/j.cardfail.2014.12.006 CrossRefPubMed
18.
Zurück zum Zitat Deo SV, Sharma V, Cho YH et al (2014) De novo aortic insufficiency during long-term support on a left ventricular assist device: a systematic review and meta-analysis. Asaio J 60:183–188. doi:10.1097/MAT.0000000000000042 CrossRefPubMed Deo SV, Sharma V, Cho YH et al (2014) De novo aortic insufficiency during long-term support on a left ventricular assist device: a systematic review and meta-analysis. Asaio J 60:183–188. doi:10.1097/MAT.0000000000000042 CrossRefPubMed
19.
Zurück zum Zitat Grupper A, Park SJ, Pereira NL et al (2015) Role of ventricular assist therapy for patients with heart failure and restrictive physiology Improving outcomes for a lethal disease. J Heart Lung Transplant 34:1042–1049. doi:10.1016/j.healun.2015.03.012 CrossRefPubMed Grupper A, Park SJ, Pereira NL et al (2015) Role of ventricular assist therapy for patients with heart failure and restrictive physiology Improving outcomes for a lethal disease. J Heart Lung Transplant 34:1042–1049. doi:10.1016/j.healun.2015.03.012 CrossRefPubMed
20.
Zurück zum Zitat DeVore AD, Mentz RJ, Patel CB (2014) Medical management of patients with continuous-flow left ventricular assist devices. Curr Treat Options Cardiovasc Med 16:283 doi:10.1007/s11936-013-0283-0 CrossRefPubMedPubMedCentral DeVore AD, Mentz RJ, Patel CB (2014) Medical management of patients with continuous-flow left ventricular assist devices. Curr Treat Options Cardiovasc Med 16:283 doi:10.1007/s11936-013-0283-0 CrossRefPubMedPubMedCentral
Metadaten
Titel
Therapieformen bei fortgeschrittener Herzinsuffizienz
„Ventricular assist device“
verfasst von
M.D. P. Pergantis
T. Krabatsch
E. Potapov
F. Schönrath
Publikationsdatum
01.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Die Kardiologie / Ausgabe 2/2016
Print ISSN: 2731-7129
Elektronische ISSN: 2731-7137
DOI
https://doi.org/10.1007/s12181-016-0051-y